The COVID-19 Vaccine Janssen has today been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA).
This is the fourth COVID-19 vaccine to be authorised by the UK’s independent regulator and is the first to be approved for protection against COVID-19 with a single dose.
Dr June Raine, MHRA Chief Executive, said:
We have undertaken a thorough review of the conditional marketing authorisation application submitted by Janssen, including the information on quality, safety and effectiveness. I am pleased to confirm today that this authorisation has been granted.
This is encouraging news for the public and the healthcare sector. We now have four safe and effective vaccines approved to help protect us from COVID-19.
Our work does not end here. We are continually monitoring all COVID-19 vaccines in use once they have been approved to ensure that the benefits in protecting people against the disease continue to outweigh any risks.
The safety of the public will always come first – you can be absolutely sure of our commitment to this.
